• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

anti-Tau

green light go go ahead advance yes streetlight
Biotech

Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step

Janssen has picked a tau vaccine from its collaboration with neurodegenerative-focused biotech AC Immune to advance into further development.
Annalee Armstrong Nov 30, 2022 10:40am
Alzheimers dementia brain puzzle drug therapy

TauRx plans Alzheimer's approval filing despite phase 3 failings

Oct 6, 2022 8:00am
Alzheimers dementia brain memory loss

J&J's Janssen aims for 'sweet spot' of Alzheimer's R&D

Aug 1, 2022 8:00am
A nurse preparing a medical injection

AC Immune, Janssen Alzheimer's vaccine spurs tau antibodies

Feb 15, 2022 9:20am
A sheet of paper reading venture capital

Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work

Sep 29, 2021 7:00am
Biogen biologics plant in Denmark

Biogen, Ionis say Alzheimer's phase 1b drug is safe, tolerable

Jul 27, 2021 11:00am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy